Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Melatonin as a neuroprotective treatment in preterm infants
2008-004740-36Phase 2Terminated
- Sponsor
- Imperial College London
- Start
- May 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in traumatic brain injury (TBI) and prematurity and low birth weight comparing Melatonin with Placebo (2 arms). Primary endpoint: Preserved fractional anisotropy. Started May 2011; status: terminated.
02
Drugs
melatonin
03
Conditions
traumatic brain injury (TBI)prematurity and low birth weight
Beyond the preview
Go deeper on 2008-004740-36.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-004740-36.